title: Timing of Symptomatic Pulmonary Embolism with Warfarin Following Arthroplasty.
abstract: The purpose is to determine the incidence and timing of pulmonary embolism for patients receiving warfarin for thrombo-prophylaxis following total joint arthroplasty (TJA). Current guidelines for duration of prophylaxis are nonspecific. Chemical prophylaxis carries the risk of bleeding and associated periprosthetic joint infection. We retrospectively studied 26,415 primary and revision TJA cases performed at our institution between 2000 and 2010. The overall 90-day rate of symptomatic PE was 1.07%. Fatal PE rate was 0.02%. Out of 283 documented symptomatic PE cases, 81% occurred within three postoperative days, 89% within one postoperative week, and 94% within two postoperative weeks. The risk of symptomatic PE appears to be highest during the first week after TJA. Efforts must be made to minimize risk during this period.
authors: Orthopaedic Surgery at the Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, PA.
authors: Javad
authors: J
authors: Parvizi
authors: Orthopaedic Surgery at the Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, PA.
authors: Ronald
authors: R
authors: Huang
authors: Orthopaedic Research at the Rothman Institute, Thomas Jefferson Hospital, Philadelphia, PA.
authors: Ibrahim J
authors: IJ
authors: Raphael
authors: Orthopaedic Research at the Rothman Institute, Thomas Jefferson Hospital, Philadelphia, PA.
authors: Mitchell G
authors: MG
authors: Maltenfort
authors: Orthopaedic Surgery at the Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, PA.
authors: William V
authors: WV
authors: Arnold
authors: Orthopaedic Surgery at the Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, PA.
authors: Richard H
authors: RH
authors: Rothman
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D001178:Arthroplasty / Q000009:adverse effects*; D002648:Child; D005260:Female; D006470:Hemorrhage; D006801:Humans; D015994:Incidence; D007592:Joint Diseases / Q000150:complications / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D011655:Pulmonary Embolism / Q000150:complications* / Q000453:epidemiology* / Q000517:prevention & control; D012189:Retrospective Studies; D013997:Time Factors; D014859:Warfarin / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000925:Anticoagulants; D014859:Warfarin
keywords: anticoagulation; arthroplasty; hip; knee; pulmonary embolism; venous thromboembolism